Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability,
bulk quotes, proforma invoice requests, or other billing issues.
Technical.Support@LSBio.com - To request technical information requests about an LSBio product
or its application.
Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution
agreements, or general business development.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
(applications tested for the base form of this product only)
Specificity and Use
MAP1LC3A / LC3A antibody was raised against a synthetic peptide made to a C-terminal region of the human LC3I protein (within residues 50-120). [Swiss-Prot Q9H492].
This LC3I antibody specifically detects the cytosolic form of LC3 before it gets converted into LC3II during autophagy.
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
MAP1LC3A Antibody, ATG8E Antibody, LC3 Antibody, LC3A Antibody, MAP1BLC3 Antibody, MAP1A/1B light chain 3 A Antibody, MAP1A/MAP1B LC3 A Antibody, MAP1A/MAP1B light chain 3 A Antibody, MAP1ALC3 Antibody
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene.
Immunohistochemistry: LC3I Antibody - IHC of LC3I in mouse testis using DAB with hematoxylin counterstain. This image was taken for the unconjugated form of this product. Other forms have not been tested.
Immunocytochemistry
Immunocytochemistry/Immunofluorescence: LC3I Antibody - LC3I antibody was tested in Neuro2a cells with FITC (green). Nuclei were counterstained with DAPI (blue). This image was taken for the unconjugated form of this product. Other forms have not been tested.
Western blot
Western Blot: LC3I Antibody - WB analysis of LC3I in Neuro2A cell lysate. This image was taken for the unconjugated form of this product. Other forms have not been tested.